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Abstract
Schistosomiasis is a disease caused by parasites of the genus Schistosoma, currently
affecting more than 200 million people. Among the various species of this parasite that infect
humans, S. mansoni is the most common. Pharmacological treatment is limited to the use of
a single drug, praziquantel (PZQ), despite reports of parasite resistance and low efficacy. It
is therefore necessary to investigate new potential schistosomicidal compounds. In this
study, we tested the efficacy of epiisopilosine (EPIIS) in a murine model of schistosomiasis.
A single dose of EPIIS (100 or 400 mg/kg) administered orally to mice infected with adult S.
mansoni resulted in reduced worm burden and egg production. The treatment with the lower
dose of EPIIS (100 mg/kg) significantly reduced total worm burden by 60.61% (P < 0.001),
as well as decreasing hepatosplenomegaly and egg excretion. Scanning electron micros-
copy revealed morphological changes in the worm tegument after treatment. Despite good
activity of EPIIS in adult S. mansoni, oral treatment with single dose of EPIIS 100 mg/kg had
only moderate effects in mice infected with juvenile S. mansoni. In addition, we performed
cytotoxicity and toxicological studies with EPIIS and found no in vitro cytotoxicity (in HaCaT,
and NIH-3T3 cells) at a concentration of 512 μg/mL. We also performed in silico analysis of
toxicological properties and showed that EPIIS had low predicted toxicity. To confirm this,
we investigated systemic acute toxicity in vivo by orally administering a 2000 mg/kg dose to
Swiss mice. Treated mice showed no significant changes in hematological, biochemical, or
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histological parameters compared to non-treated animals. Epiisopilosine showed potential
as a schistosomicidal drug: it did not cause acute toxicity and it displayed an acceptable
safety profile in the animal model.
Introduction
Brazilian biodiversity has been studied extensively and increasing numbers of studies related
to plant species and natural resources have contributed to new therapeutic alternatives. An
example of this development concerns the Pilocarpus microphyllus Stapf ex Wardlew species,
popularly known as jaborandi, originating from North and Northeast Brazil [1,2]. Pilocarpine
alkaloid is produced commercially by extraction from jaborandi leaves; the alkaloid is used
commercially for eye procedures and treatment of glaucoma, and is therefore of great eco-
nomic interest [3,2].
Jaborandi leaves, like other plant species, contain several bioactive metabolites whose phar-
macological and physiological properties have not been fully elucidated or are still being stud-
ied; they also contain the epiisopiloturine (EPI), an alkaloid with antischistosomal activity [4,
5, 6, 7, 8].
EPIIS, or (3R,4S)3[(S)hydroxy(phenyl)methyl]4[(3methyl3H1λ2 imidazolidin4yl) methyl]
oxolan 2 one (Fig 1), is another alkaloid from jaborandi that has been reported to act as a
peripheral parasympathetic nervous system stimulant [5]. Despite few studies having focused
on EPIIS biological activities, its in vitro activity against S. mansoni has been previously
reported [2]. These results highlighted the need to perform in vivo studies of EPIIS, primarily
regarding its possible use in the treatment of schistosomiasis. Moreover, it is important to eval-
uate possible toxicity, as acute toxicity studies in animals are used to fulfill various require-
ments related to the control of risks to human health and the environment [9,10].
In this study, we evaluated the in vivo antischistosomal activity of EPIIS against adult and
juvenile S. mansoni worms. The effects of this alkaloid on tegument morphology were investi-
gated via scanning electron microscopy (SEM), and effects on egg laying and hepatosplenome-
galy reduction were also recorded. Furthermore, we evaluated in vitro cytotoxicity in different
cell lines and in silico and in vivo acute toxicity.
Materials and methods
EPIIS purification
EPIIS alkaloid was purified from biomass generated by production of pilocarpine salts. The
biomass assessment process was as previously described [11]. Alkaloids were extracted by
a process based on acidification and filtration, followed alkalization [11]. EPIIS isolation
was carried out using high performance liquid chromatography (HPLC) according to pre-
viously described methods [2]. Mass spectrometry was used to evaluate the purity and mono-
isotopic molecular mass of EPIIS (AmaZon SL, Bruker Daltonics, Bremen, Germany),
acquired in a mass range of m/z 100 to 400 Da, and the positive electrospray mode was used.
MS/MS was performed in manual mode with fragmentation of the precursor ion by collision
induced dissociation (CID) using He as the collision gas. Precursor ions were selected within
an isolation width of 2 Da and scans were accumulated with variable RF signal amplitudes
[11].
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In vivo assay against S. mansoni
Schistosoma strain and hosts. We used S. mansoni BH strain Belo Horizonte, Minas
Gerais, Brazil, maintained in the planorbid mollusc Biomphalaria glabrata as the intermediate
host. For definitive hosts, Mus musculus female BALB/c SPF, weighing 20 g at 4 weeks of age,
were previously infected using exposure to a suspension containing 70 cercariae by the tail
immersion technique, as described [12]. After infection, the animals (8 per group) were main-
tained in vented rack system, Ventilife Alesco mini-isolators with 32 cm length per floor area
(451 cm2), temperature 24˚C, autoclaved shavings, ration feed and ad libitum water. For
Fig 1. Chemical structure of EPIIS alkaloid with its heteroatoms and stereoisomer annotated. EPIIS possesses 39 atoms (C16H18O3N2).
https://doi.org/10.1371/journal.pone.0196667.g001
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management and monitoring of animals, two weekly shavings were performed and behavior
was observed until the end of the experiment. All studies were performed at the Biology Insti-
tute—Helminthology Laboratory of Neglected Diseases at the Department of Animal Biology,
IB, Unicamp, São Paulo, Brazil.
Animal groups and in vivo treatments. We analyzed the effect of EPIIS in mice with
adult S. mansoni infections (patent infections). In the first step, animals were divided into two
groups (n = 8) and were treated 60 days post-infection (dpi). Group I animals were treated
with a single dose of 400 mg/kg EPIIS, and group II animals (control group) were given 0.3
mL phosphate buffered saline (PBS). In the second step, animals were divided into two groups
(n = 8) and were also treated 60 days dpi. Group III animals were treated with a single dose of
100 mg/kg EPIIS, and group IV animals (control group) were given 0.3 mL PBS. In all groups,
EPIIS solubilized with PBS was administered by the oral route.
Subsequently, on the basis of their in vivo activity against adult schistosomes, EPIIS was
tested in mice harboring juvenile S. mansoni (pre-patent infection). In this case, 21 days post
infection, a group of 8 mice were treated with a single 100 mg/kg oral dose of EPIIS, and the
other group of 8 untreated mice served as controls.
Worm recovery and treatment analysis. The analyses were performed two weeks after
treatment. Mice were euthanized via cervical dislocation and adult worms were retrieved
through perfusion of the hepatic portal system and mesenteric veins as described [13]. The
percentage of worm reduction (WR) was calculated as described [14]. The counting of the
eggs eliminated through the feces (OPG) was performed using the Kato-Katz quantitative
method [15]. The percentages of the various egg developmental stages: immature, mature, and
dead eggs (the oogram method) were calculated from the small intestinal wall of infected mice
as described [16]. No animals died before the final trial period (75 days).
Scanning electron microscopy (SEM). For microscopic analysis, a new group of animals
was treated separately following the treatment scheme reported above, but with the difference
that mice were euthanized via cervical dislocation 48 h after treatment. Adult S. mansoni
worms were retrieved as described above. For preparation and analysis, the worms were
washed with sodium cacodylate buffer (0.1 M), fixed in 2.5% glutaraldehyde (pH 7.4, Merck)
for 24 h, and then fixed in 1% osmium tetroxide for 1 h. Specimens were dehydrated with
increasing concentrations of ethanol (70%, 80%, 90%, and 100%) for 30 min each, dried in a
critical point dryer, mounted on stubs, metalized with gold particles using a sputter coater,
and finally analyzed and photographed using an electron microscope (Jeol-JSM-820).
In silico analysis of toxicological properties
To analyze the toxicological parameters, we first needed to calculate LogP (lipophilicity), total
polar surface area, number of hydrogen bond donors and acceptors, molecular weight and
number of rotatable bonds for comparison with molecules that have similar characteristics. All
these data and in silico toxicological properties were calculated using pkCSM software, an in sil-
ico tool web server maintained by VLS3D (Cambridge University) that graph-based signatures
to develop predictive models of central toxicological properties for drug development [17].
Cell culture and in vitro cytotoxicity assays
Murine fibroblasts (NIH-3T3) and human keratinocytes (HaCaT) cells were grown in Dulbec-
co’s modified Eagle’s medium supplemented with 10% fetal bovine serum and 1% antibiotic
solution. The cells were maintained in an incubator under humidified atmosphere with 5%
CO2 at 37˚C. For real-time cell analysis (RTCA, xCelligence, Roche, Switzerland), the NIH-
3T3 and HaCaT cells were seeded in culture plates containing electronic biosensors. After 24 h
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of culture, cells were treated with EPIIS or no drug (control). The concentrations of EPIIS
were 32 and 512 μg/mL (equivalent to 111.8 and 1790.2 μM, respectively), and the adhered cell
rates were measured every 30 min for 137 h.
Acute toxicity evaluation
The in vivo toxicological evaluation of EPIIS was performed using the acute toxic class test [18],
guide number 423 [9]. Female Swiss mice were divided into two groups of three animals each: a
control group treated orally with a solution of 5% DMSO in saline and a group treated orally
with EPIIS. The drug was solubilized at the highest recommended dose (2000 mg/kg body
weight) in a solution of 5% DMSO in saline. Clinical and behavioral parameters were evaluated
according to the OECD’s Guide for Recognition, Evaluation and Use of Clinical Signals [19].
Evaluation of hematological and biochemical parameters. After the 14th day of obser-
vation, the animals were euthanized by asphyxiation in a CO2 chamber and blood samples
were collected from the animals via the orbital plexus. For biochemical analyses, the material
was centrifuged at 1200 x g for 5 min before determining glucose, urea, creatinine, aspartate
aminotransferase (AST), alanine aminotransferase (ALT), total cholesterol, HDL, LDL, alka-
line phosphatase, total protein, albumin, and globulin levels. The values for red blood cells, leu-
kocytes, platelets, hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin
were determined immediately after collection by means of the automatic hematology Advia
120/hematology (Siemens) analyzer. Differential leukocyte counts were performed on smears
stained with May-Gru¨nwald-Giemsa [20,21].
Histopathological analysis. Immediately after euthanasia, fragments of liver, spleen, kid-
ney, brain, lung, stomach, small intestine, and large intestine were collected and fixed in 10%
buffered formaldehyde. After fixation, the organs were dehydrated in serial dilutions of ethyl
alcohol for 1 h in each dilution, diaphanized in xylene for 30 min, and soaked in paraffin for 5
min. Sections of these organs (4 μm) were stained with hematoxylin and eosin and examined
under a light microscope [22].
Ethical conduct of research
The animals used in the in vivo studies were provided by Multidisciplinary Center for Biologi-
cal Research (CEMIB) of the State University of Campinas. All experiments were approved by
the Ethics Commission for the Use of Animals (CEUA/UNICAMP, protocol n˚ 2170–1),
according to Brazilian Society of Science in Laboratory Animals (SBCAL) and Ethical Princi-
ples for the Use of Animals.
Statistical analysis
GraphPad Prism (version 5.0) software was used for analyses of data significance. For therapeu-
tic effect assays (in vivo assays) ANOVA and Dunnett’s test were used to analyze the statistical
significance of differences between mean experimental and control values. For the RTCA assay
we analyzed mean and standard deviation. A P value of< 0.05 was considered significant.
Results
EPIIS purification
The mass spectrometry analysis showed that the separation methods used were successful.
MS/MS analysis showed a pseudomolecular ion with m/z 286.9 Da [M + H]+ and a MS2 frag-
ments with m/z 268.8 Da [M–H2O + H]+ and 180.7 Da. This ‘‘molecular fingerprint” con-
firmed EPIIS (Fig 2).
Epiisopilosine for schistosomiasis without toxicity
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EPIIS showed activity against adult S. mansoni-infected mice (patent
infections)
In mice infected by adult S. mansoni, there was a significant reduction in worm burden with
oral treatment by EPIIS (Fig 3). A single dose of EPIIS of 400 mg/kg reduced worm burden by
57.78% (P < 0.001). At a dose of 100 mg/kg, the total worm burden reduction was 60.61%
Fig 2. EPIIS mass spectrum. (A) pseudomolecular ion with m/z 286.9 Da [M + H]+. (B) MS2 fragments with m/z 268.8 Da [M—H2O + H]
+ e 180,7 Da.
https://doi.org/10.1371/journal.pone.0196667.g002
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(P< 0.001) that of the infected untreated controls. The total, male and female worm burdens
following treatment of S. mansoni infections with EPIIS are shown in Fig 3.
Because the single dose of 400 mg/kg showed no difference in terms of worm burden com-
pared with 100 mg/kg dose, we showed the results for eggs production, liver and spleen
weights, and scanning electron microscopy investigations only for the lowest dose investigated
(100 mg/kg).
EPIIS disrupted egg development as well as liver and spleen weights in
mice harboring patent infections
The effects of EPIIS on egg development stages (oogram pattern) at 15 days after treatment are
shown in Fig 4A. Administration of single dose of 100 mg/kg reduced the number of immature
eggs by 45.84%. The oogram method revealed a significant increase in the percentage of dead
eggs in treated mice (19.16%) compared with the control group (2.25%).
In feces samples collected from mice, the Kato-Katz method revealed that EPIIS signifi-
cantly reduced the number of eggs compared with the control group (untreated), with a
Fig 3. Effect on worm burden of a single oral dose of EPIIS administered to mice harboring a 60-day-old adult S.
mansoni infection, stratified by sex. Points represent data from individual mice that were infected and treated with EPIIS,
or infected and untreated (control). Each treated group was compared to its corresponding untreated group. The horizontal
bars represent median values. P< 0.05, P< 0.01, P< 0.001 compared with untreated groups.
https://doi.org/10.1371/journal.pone.0196667.g003
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Fig 4. Effect on egg development and on Stoll egg count of a single dose 100 mg/kg of EPIIS administered to mice
harboring a 60-day-old adult S. mansoni infection. (A) EPIIS effect on egg development stages (oogram) (B) Effect
on Stoll egg count. Points represent data from individual mice that were infected and treated with EPIIS, or infected
and untreated (control). The horizontal bars represent median values. P< 0.01 and P< 0.001 compared with
untreated groups.
https://doi.org/10.1371/journal.pone.0196667.g004
Epiisopilosine for schistosomiasis without toxicity
PLOS ONE | https://doi.org/10.1371/journal.pone.0196667 May 11, 2018 8 / 19
reduction of 58% (P<0.001) at dose of 100 mg/kg (Fig 4B). Furthermore, oral treatment with
EPIIS significantly decreased hepatosplenomegaly as measured by liver and spleen weights,
P< 0.01 and P< 0.05, respectively (Fig 5) compared to the control group.
EPIIS caused changes in the tegument morphology of adult S. mansoni
In the control (untreated) group, the oral and ventral sucker, tubercles, and spines of male and
female worms showed normal integrity (Fig 6A–6D). EPIIS treatment caused changes to the
tegument in both males and females (Fig 6E–6L), but tegumental damage was particularly evi-
dent in male worms. The male worms showed extensive peeling of tubercles, absence of spines,
and the formation of protuberances in the dorsal region (Fig 6I–6L).
EPIIS shows moderate activity against juvenile S. mansoni-infected mice
(pre-patent infections)
Because EPIIS at dose of 100 mg/kg was the most potent against S. mansoni adults, we also
analyzed the effects of EPIIS on juvenile S. mansoni worms. The treatment of juvenile S. man-
soni-infected mice with single 100 mg/kg oral dose of EPIIS showed a moderate reduction in
worm burden of 58.06% compared to the control group (Fig 7A). Analysis of the oogram pat-
tern showed reductions in the number of immature eggs of 58.60% (Fig 7B). In feces samples,
the Kato-Katz technique revealed egg reduction of 64.18% compared to the control group
(Fig 7C).
Fig 5. Effect of EPIIS on relative liver and spleen weights. Points represent data from individual mice that were
infected and treated with EPIIS or were infected and untreated (control). The horizontal bars represent median values.
P< 0.05 and P< 0.01 compared with untreated groups.
https://doi.org/10.1371/journal.pone.0196667.g005
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EPIIS gave low probability toxicity predictions
In silico analysis of LogP, total polar surface area, number of hydrogen bond donors and accep-
tors, molecular weight and number of rotatable bonds are shown in Table 1. We analyzed the
predicted toxicity on human ether-à-go-go-related gene (hERG) inhibitor I and II, to evaluate
whether EPIIS caused effects on cardiac repolarization. In addition, we analyzed whether EPIIS
caused hepatotoxicity, because the liver is substantially affected in schistosomiasis; in addition,
liver is primarily responsible for the first-pass metabolism. The human maximum tolerated
dose and skin sensitization were also analyzed, because it is important to know whether the
dose causes allergic responses. All results for toxicity properties are shown in Table 2.
Effect of EPIIS on cell viability
Cytotoxic activity of EPIIS was determined via real-time cell index analysis (RTCA) on two
normal cell lines: NIH-3T3 and HaCaT. RTCA showed that adhesion indices in both NIH-
3T3 and HaCaT cells were decreased by EPIIS at a concentration of 32 μg/mL. However, no
significant decrease in cell adhesion indices were found in comparison to the control groups
when EPIIS was used at 512 μg/mL (Fig 8).
EPIIS did not cause acute toxicity in mice
In acute toxicity tests in mice, no animal showed signs of toxicity (cyanosis, piloerection, con-
tortion, eyelid ptosis, tremors, seizures, ataxia, or diarrhea) and all mice survived the 14 days
Fig 6. Scanning electron microscopy of S. mansoni adults retrieved 48 h after treatment with EPIIS (100 mg/kg). A-D: Control group—untreated; E–L:
Male and female worms. The arrows show damage to tegument with reduction in the size of the spines, and damage to the oral and ventral suckers in male
worms, followed by body corrugation in female worms. Image bar scale: (A) 100X___10 kv; (B) 120X ___10 kv; (C-D) 180X ___10 kv; (E-F) 127X ___10 kv;
(G-H) 250X___10 kv; (I- L) 350X___10 kv.
https://doi.org/10.1371/journal.pone.0196667.g006
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examination period. Therefore, the LD50 was over 2000 mg/kg. Furthermore, there were no
significant differences between the treated and control groups in terms of parameters of motor
activity, respiratory rate, and corneal and atrial reflexes.
EPIIS did not cause biochemical or hematological changes in mice. The analysis of
hematological parameters is more accurate for predicting the toxic effects of drugs in humans
when the data are translated from animal studies [23, 24]. The hematological parameters of
mice treated with EPIIS were all within the reference range (Table 3). The biochemical param-
eters are shown in Table 4. Total cholesterol and high-density lipoprotein (HDL) were signifi-
cantly higher in the EPIIS treatment group than in the control group (P< 0.05 and P< 0.001,
respectively).
EPIIS did not cause histopathological changes. A detailed study of histological sections
of liver, spleen, brain, lung, stomach, small intestine, and large intestine from Swiss mice
treated with oral doses of 2000 mg/kg of EPIIS revealed no morphological changes compared
to the control group. No pathogenic changes characteristic of toxicity were found. Representa-
tive photomicrographs of histological sections of the liver, spleen, and kidney are shown in
Fig 9.
Discussion
Our data suggested that the methods used for EPIIS purification were successful because the
fragments found on mass spectrometry were of a molecular structure that accorded with previ-
ously reported structures [2].
Our mouse model of schistosomiasis showed that EPIIS affected adult S. mansoni survival,
inducing tegumental alterations in the oral and ventral suckers of parasites. EPIIS also affected
egg production. Unlike praziquantel, which acts primarily against the adult worm, oral treat-
ment with EPIIS also showed moderate efficacy against juvenile S. mansoni.
The worm’s tegument is well-recognized as an important drug target and study model in
schistosomiasis [25,26]. Apart from having a direct effect on survival, tegumental alterations
might result in exposure of parasite antigens to the host immune system [27]. According to
Xiao et al. [28], damage to the suckers may result in loss of ability to adhere to blood vessels,
rendering ingestion of nutrients from the blood more difficult. Other authors observed similar
tegumental alterations after evaluating various compounds in vivo, e.g., EPI and phytol [8, 29,
30]. EPIIS has effects similar to those of pilocarpine on peripheral parasympathetic nervous
system [5]. Thus, as pilocarpine was previously reported to exert no cholinergic effect on the
Fig 7. Antischistosomal effect of a single 100 mg/kg oral dose of EPIIS administered to mice harboring juvenile S.
mansoni infection. (A) EPIIS effect on worm burden. (B) EPIIS effect on egg development stages (oogram) (C) Effect
on Stoll egg count. Points represent data from individual mice that were infected and treated with EPIIS, or infected
and untreated (control). The horizontal bars represent median values. P< 0.01 and P< 0.001 compared with
untreated groups.
https://doi.org/10.1371/journal.pone.0196667.g007
Table 1. Physicochemical parameters through in silico analysis of EPIIS using pkCSM methodology.
Descriptor Preferred EPIIS
Molecular Weight (g/mol) < 500 286.331
LogP 1–3 1.4854
Rotatable Bonds  10 4
Acceptors  10 5
Donors  5 1
Surface Area < 140 Å2 (oral) 122.745
https://doi.org/10.1371/journal.pone.0196667.t001
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neuromuscular system of schistosomes [31], it could be that EPIIS also does not exert this
action on Schistosoma. The mechanism of parasite killing by EPIIS may be associated with
high titers of serum antibodies against tegumental antigens; serum antibodies from mice can
bind the surface membrane of EPIIS-exposed adult worms, as was shown for arachidonic acid
[32].
Our results also showed a significant decrease in the total number of eggs, both in terms of
the percentage of immature eggs and the increase in the percentage of mature and dead eggs.
Thus, EPIIS could affect the fecundity of the worms, especially female worms, decreasing their
ability to lay eggs. We may suspect direct ovicidal action, taking into account the increase in
the number of dead eggs [29,33]. The results presented here regarding egg reduction were also
observed by Guimarães et al. (2015) [8] in a study on the effects of the alkaloid EPI on S. man-
soni at a concentration of 100 mg/kg. Our results revealed that treatment with 100 mg/kg
EPIIS caused a reduction in total worm burden. In the literature however, we note that the
majority of compounds tested against S. mansoni showed activity at doses higher than 100 mg/
kg, e.g., dihydroartemisinin [34], and nerolidol [30], whereas (-)-6,6’-dinitrohinokinin
reduced total worm burden at a concentration of 100 mg/kg [35] but to a lesser extent than did
EPIIS in the present study. In addition, the treatment produced significant reduction in female
worms; this is important as the females are responsible for oviposition, producing about 300
eggs/day, all of which are viable, metabolically active, and highly antigenic [36]. Our observa-
tion of higher activity of EPIIS on female S. mansoni worms accords with results from a previ-
ous in vivo study investigating natural antischistosomal products and natural product-derived
compounds such as dihydroartemisinin [34]. We therefore speculate that EPIIS may act on
different targets in males and females, however, the mechanism of action remains to be
elucidated.
In addition to the therapeutic evaluation of EPIIS against S. mansoni, we performed in vitro
cytotoxicity tests. These assays are essential in the early stages of drug development as they pro-
vide an estimation of the starting dose and range of concentrations to be used in in vivo non-
clinical stages [10, 37]. Our results accord with findings reported for other imidazole com-
pounds that did not demonstrate strong toxic activity in mammalian cells (acute toxicity and
cytotoxicity) [38]. Interestingly, among all the EPIIS concentrations tested on non-tumoral
fibroblast cells, 32 μg/mL was the only concentration that induced reduction in cell viability. It
is known that poorly water-soluble molecules tend to form aggregates and/or precipitates
depending on various factors including physicochemical properties, concentration, pH, salt,
and ionic strength [39,40]. This phenomenon may be exemplified by phthalocyanines (hydro-
phobic photosensitizers used for medical applications) where the increase of their concentra-
tion in aqueous media led to aggregate formation that impaired their effectiveness [41]. We
suggest that EPIIS, also a hydrophobic molecule, had a similar dose-dependent behavior in the
in vitro assays because significant cytotoxicity was observed with a 32 μg/mL EPIIS treatment
while no cytotoxicity was shown with the dose of 512 μg/mL (16x higher). Detailed analysis of
EPIIS behavior in solution should be considered in further studies.
Table 2. In silico analysis of toxicological properties of EPIIS predicted using the pkCSM methodology.
Model name Unit Preferred EPIIS
Max. tolerated dose (human) log mg/kg/day < 0.477 0.451
hERG I inhibitor - No No
hERG II inhibitor - No Yes
Hepatotoxicity - No Yes
Skin sensitization - No No
https://doi.org/10.1371/journal.pone.0196667.t002
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However, some azoles, such as ketoconazole, display high renal and hepatic toxicity by
binding to mammalian P450 enzymes, including P450 3A4 and several steroid hydroxylases
[42]. Thus, because of the known toxicity of some alkaloids, we performed a toxicity prediction
study and an acute toxicity study of mice treated with EPIIS.
The in silico analysis revealed that physicochemical parameters of EPIIS were within pre-
ferred specifications. The predicted toxicity showed that EPIIS had a human maximum toler-
ated dose with value within preferred specifications. The pkCSM prediction of hERG
inhibition considers the IC50 values of about 360 compounds (for hERG I analysis) and molec-
ular parameters of more 800 compounds (for hERG II analysis) [10, 43,44]. In our study, the
Fig 8. In vitro cytotoxicity assay with EPIIS. Adhesion indices of NIH-3T3 and HaCaT cells treated with EPIIS. The concentrations of EPIIS were 32 or
512 μg/mL and the adhered cell rates were measured every 30 min for 137 h.
https://doi.org/10.1371/journal.pone.0196667.g008
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hERG II model, but not the hERG I model showed positive results. These data point to a possi-
ble cardiotoxic effect of EPIIS, but as different datasets were applied in the same model, the
prediction results may show some variability, as was shown for the BPP-brachyNH2 peptide
[10]. More investigations are needed in this respect in view of the known parasympathomi-
metic action of the drug on vertebrate heart and vascular smooth muscles. In addition,
although the in silico study predicted hepatotoxicity for EPIIS, no alteration was observed in
the in vivo serum biochemical parameters, including aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), as well as in the liver histopathological analysis.
With respect to acute toxicity, EPIIS was considered safe, with LD50 above 2000 mg/kg. In
addition, all hematological parameters for mice in EPIIS treatment group were within the ref-
erence ranges, indicating that the tested alkaloid may not have harmful effects on bone marrow
function and may not induce anemia. Furthermore, we observed no marked alterations in
serum biochemical parameters of treated animals compared to those of control animals.
Table 3. Hematological parameters of Swiss mice treated with EPIIS by oral route.
Parameters Control EPIIS
RBC (x 10/μL) 9.34 ± 0.0284 9.84 ± 0.287
Hemoglobin (g/dL) 13.9 ± 0.148 14.6 ± 0.410
Globular volume (%) 43.0 ± 0.365 44.8 ± 1.49
MCV (fL) 45.8 ± 0.121 45.6 ± 0.711
MCHC (%) 32.3 ± 0.347 32.5 ± 0.634
Total leukocyte count (/μL) 10.0 ± 0.479 10.8 ± 0.856
Lymphocytes (/μL) 8.90 ± 0.443 7.90 ± 1.60
Eosinophils (/μL) 0.124 ± 0.0394 0.0243 ± 0.0243
Monocytes (/μL) 0.100 ± 0.00479 0.101 ± 0.0538
Platelets (thousand/μL) 1030 ± 50.9 944 ± 72.6
Values are presented as means ± SEM. Number of animals/group = 6. RBC: Red blood cells; MCV: mean corpuscular volume; MCHC: mean corpuscular hemoglobin
concentration.
https://doi.org/10.1371/journal.pone.0196667.t003
Table 4. Biochemical parameters in sera obtained from Swiss mice treated with EPIIS by oral route.
Parameters Control EPIIS
ALT (UI/L) 83.3 ± 10.5 122 ± 25.6
AST (UI/L) 111 ± 13.6 96.2 ± 11.6
Glucose (mg/dL) 164 ± 2.14 150 ± 7.07
Urea (mg/dL) 83.3 ± 7.25 89.2 ± 6.49
Creatinine (mg/dL) 0.167 ± 0.0422 0.317 ± 0.0749
Total Cholesterol (mg/dL) 91.7 ± 2.32 138 ± 16.9
HDL (mg/dL) 27.3 ± 2.95 55.2 ± 4.71
LDL (mg/dL) 72.7 ± 8.33 61.7 ± 21.2
Alkaline Phosphatase (UI/L) 85.0 ± 15.5 103 ± 8.17
Total Protein (g/dL) 5.23 ± 0.0558 6.55 ± 0.742
Albumin (g/dL) 1.96 ± 0.0623 2.16 ± 0.141
Globulin (g/dL) 3.27 ± 0.0269 4.39 ± 0.621
Values are presented as means ± SEM. Number of animals/group = 6.
Asterisks indicate that differences compared to the control were significant with P< 0.001, and P< 0.05. ALT:
alanine transaminase; AST: aspartate transaminase; HDL: high-density lipoprotein: LDL: low-density lipoprotein.
https://doi.org/10.1371/journal.pone.0196667.t004
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However, more studies are needed to understand the effect of EPIIS on increased cholesterol
and HDL values, although the increase in lipoprotein can be beneficial in hypercholesterol-
emia patients. In addition, the increase in total cholesterol may have occurred due only to the
Fig 9. Photomicrographs of histological sections of liver (A1, A2), spleen (B1, B2), kidney (C1, C2), lung (D1, D2)
and brain (E1, E2) obtained from Swiss mice of control group (first column) and group treated with 2000 mg/kg
EPIIS (second column). Hematoxylin & eosin, 400 X magnification, bars = 50 μm.
https://doi.org/10.1371/journal.pone.0196667.g009
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EPIIS effect on HDL fraction. Corroborating with the biochemical results obtained for this
study, there were no significant histopathological changes or morphological differences in ana-
lyzed organs (liver, spleen, kidneys, brain, lungs, heart, stomach, small intestine, and large
intestine) for mice in the control group and those treated with EPIIS.
In conclusion, the present study results demonstrated that the main action of EPIIS was on
female worm burden. In addition, the treatments caused significant reduction in egg burden
and morphological changes in the parasites, parasitological parameters essential for drug dis-
covery for schistosomiasis. The alkaloid did not show in vitro cytotoxicity against the cell lines
tested at a concentration of 512 μg/mL, nor in vivo toxicity following single dose administra-
tion in the experimental model. Thus, the absence of toxicity observed for this alkaloid demon-
strated an acceptable safety profile for studies in animal models aiming to investigate the
pharmacological, biotechnological, and therapeutic potential of this molecule related to its
activity against schistosomiasis.
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